MaRS Drug Development Discussion Group
TARGET IDENTIFICATION FOR CANCER: INFORMATICS AND BIOCOMPUTING AT WORK AT THE OICR
The Drug Development Discussion Group (DDD Group) is an informal moderated forum bringing together research professionals and clinicians interested in drug development.
Think of DDD Group as a Journal Club focused on global drug development issues; a place to hear candid comments from the practitioners in the field, a chance to debate and develop a rapport with industry and academic professionals you do not necessarily deal with on a daily basis.
Speaker:Francis Ouellette
Ontario Institute for Cancer Research
Associate Director, Informatics and Biocomputing and Principle Investigator
DATE | TIME | LOCATION
January 20, 200912:00PM - 1:30PM
MaRS Centre, CR3
101 College St.
Toronto, ON
REGISTRATION
Registration is free but required for each discussion group. Please bring your own lunch.MORE INFORMATION
For more information on this series, please contact: events@marsdd.comOr click here to find out more about the series >>
UPCOMING EVENTS
PAST EVENTS
- March 27, 2008
MaRS Drug Development Discussion Group - Structure-Guided Discovery Without Structures: Computer-aided design of GPCR ligands - February 27, 2008
MaRS Drug Development Discussion Group - Formulation: Giving new life to naturally occurring un-patentable compounds - January 25, 2008
Drug Development Discussion Group - Novel therapeutic targets for preventing bone loss in osteolytic disease - December 18, 2007
MaRS Drug Development Discussion Group - Outsourcing Preclinical Development - October 23, 2006
MaRS Drug Development Discussion Group - Chance and Necessity in Drug Discovery: The case history of calcimimetic drugs - August 31, 2006
Drug Development Discussion Group - Structure-based Lead Generation and Optimization - June 29, 2006
Drug Development Discussion Group - Exploratory IND - April 27, 2006
Drug Discussion Group - BioMarkers in Clinical Trials
